Genbank Acc. No. U64197. |
SWISS-PROT: P48061. |
Alkhatib et al., 1996, “CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1”, Science 272:1955-1958. |
Baggiolini et al., 1994, “Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines”, Adv. in Immunol. 55:97-179. |
Barin et al., 1985, “Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients”, Science 228:1094-1096. |
Barre-Sinoussi et al., 1983, “Isolation of a T-Lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)”, Science 220:868-870. |
Beall et al., 1992, “Conversion of monocyte chemoattractant protein-1 into a neutrophil attractant by substitution of two amino acids”, J. Biol. Chem. 267:3455-3459. |
Bischoff et al., 1993, “RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors”, Eur. J. Immunol. 23:761-767. |
Blazevic et al., 1995, “Helper and cytotoxic T cell responses of HIV type 1-Infected individuals to synthetic peptides of HIV type 1 rev”, AIDS Res. & Hum Retroviruses 11:1335-1342. |
Charo et al., 1994, “Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails”, Proc. Natl. Acad. Sci. USA 91:2752-2756. |
Cheng-Mayer et al, 1991, “Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat an gp120”, J. Virol. 65:6931-6941. |
Choe et al., 1996, “The β-Chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates”, Cell 85:1135-1148. |
Clavel et al., 1986, “Isolation of a new human retrovirus from west african patients with AIDS”, Science 233:343-346. |
Cocchi et al., 1995, “Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-Suppressive factors produced by CD8+ T cells”, Science 270:1811-1815. |
Cocchi et al., 1996, “The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection”, Nature Med. 2:1244-1247. |
Daar et al., 1990, “High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates”, Proc. Natl. Acad. Sci. USA 87:6574-6579. |
Dalgleish et al., 1984, “The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus”, Nature 312:763-767. |
Daugherty et al., 1996, “Cloning expression, and characterization of the human eosinophil eotaxin receptor”, J. Exp. Med. 183:2349-2354. |
Deng et al., 1996, “Identification of a major co-receptor for primary isolates of HIV-1”, Nature 381:661-666. |
Doranz et al., 1996, “A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors”, Cell 85:1149-1158. |
Dragic et al., 1996,“HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5”, Nature 381:667-674. |
Erickson et al., 1990, “Design, activity, and 2.8 Å crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease”, Science 249:527-533. |
Feng et al., 1996, “HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor”, Science 272:872-877. |
Gallo et al., 1984, “Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS”, Science 224:500-503. |
Gardner et al., 1981, “The complete nucleotide sequence of an infectious clone of cauliflower mosaic virus by M13mp7 shotgun sequencing”, Nuc. Acids Res. 9:2871-2888. |
Gerard & Gerard, 1994, “The pro-inflammatory seven-transmembrane segment receptors of the leukocyte”, Curr. Opin. in Immunol. 6:140-145. |
Goff et al, 1981, “Isolation and properties of Moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase”, J. Virol. 38:239-248. |
Gong et al., 1996, “RANTES and MCP-3 antagonists bind multiple chemokine receptors”, J. Biol. Chem. 271:10521-10527. |
Guyader et al., 1987, “Genome organization and transactivation of the human immunodeficiency virus type 2”, Nature 326:662-669. |
Hammerskjold & Rekosh, 1989, “The molecular biology of the human immunodeficiency virus”, Biochem. Biophys. Acta 989:269-280. |
R. Horuk, 1994, “Molecular properties of the chemokine receptor family”, Trends Pharmacol. Sci. 15:159-165. |
Horuk et al., 1994, “Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line”, J. Biol. Chem. 269:17730-17733. |
Hwang et al., 1991, “Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1”, Science 253:71-74. |
Kahn et al., 1990, “The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex”, Ann. Int. Med. 112:254-261. |
Kelner et al., 1994, “Lymphotactin: A cytokine that represents a new class of chemokine”, Science 266:1395-1399. |
Kim et al., 1995, “V3-Independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate”, J. Virol. 69:1755-1761. |
Kitaura et al., 1996, “Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, cc chemokine receptor 3”, J. Biol. Chem. 271:7725-7730. |
Klatzmann et al., 1984, “T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV”, Nature 312:767-768. |
Kunz et al., 1991, “The human leukocyte platelet-activating factor receptor—cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog”, J. Biol. Chem. 267:9101-9106. |
J.M.A. Lange, 1995, “Triple combinations: Present and future”, J. AIDS Synd. & Hum. Retrovirol. 10:S77-82. |
Liu et al., 1996, “Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection”, Cell 86:367-377. |
Loestcher et al., 1996, “Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes”, J. Exp. Med. 184:963-969. |
Maddon et al., 1986, “The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain”, Cell 47:333-348. |
McDougal et al., 1986, “Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule”, Science 231:382-385. |
Miedema et al., 1994, “Changing virus-host interactions in the course of HIV-1 infection”, Immunol. Rev. 140:35-72. |
Miller & Krangel, 1992, “Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines”, Crit. Rev. in Immunol. 12:17-46. |
Mitsuya et al., 1991, “Targeted therapy of human immunodeficiency virus-related disease”, FASEB J. 5:2369-2381. |
Mitsuya et al., 1990, “Molecular targets for AIDS therapy”, Science 249:1533-1544. |
P.M. Murphy, 1994, “The molecular biology of leukocyte chemoattractant receptors”, Annu. Rev. Immunol. 12:593-633. |
Neote et al., 1993, “Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells”, J. Biol. Chem. 268:12247-12249. |
Neote et al., 1993, “Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor”, Cell 72:415-425. |
Neote et al., 1994, “Functional and biochemical analysis of the cloned duffy antigen: Identity with the red blood cell chemokine receptor”, Blood 84:44-52. |
O'Brien et al., 1990, “HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain”, Nature 348:69-73. |
Oravecz et al., 1996, “β-chemokine inhibition of monocytotropic HIV-1 infection”, J. Immunol. 157:1329-1332. |
Pal et al., 1993, “Conformational perturbation of the envelope glycoprotein gp120 of human immunodeficiency virus type 1 by solube CD4 and the lectin succinyl Con A”, Virol. 194:833-837. |
Paxton et al., 1996, “Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures”, Nature Med. 2:412-417. |
Perelson et al., 1996, “HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time”, Science 15:1582-1586. |
Ponath et al., 1996, “Cloning of the human eosinophil chemoattractant, eotaxin”, J. Clin. Invest. 97:604-612. |
Ponath et al., 1996, “Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils”, J. Exp. Med. 183:2437-2438. |
Power et al., 1995, “Molecular cloning and functional expression of a novel cc chemokine receptor cDNA from a human basophilic cell line”, J. Biol. Chem. 270:19495-19500. |
Proudfoot et al., 1996, “Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist”, J. Biol. Chem. 271:2599-2603. |
Rossi et al., 1997, “Identification through bioinformatics of two new macrophage proinflammatory human chemokines”, J. Immunol. 158:1033-1036. |
Samson et al., 1996, “Molecular cloning and functional expression of a new human cc-chemokine receptor gene”, Biochem. 35:3362-3367. |
Sattentau & Moore, 1993, “The role of CD4 in HIV binding and entry”, Philos. Trans. R. Soc. London (Biol.) 342:59-66. |
T.J. Schall, 1991, “Biology of the RANTES/SIS cytokine family”, Cytokine 3:165-183. |
Schooley et al., 1990, “Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex”, Ann. Int. Med. 112:247-253. |
Simon et al., 1991, “Diversity of G proteins in signal transduction”, Science 252:802-807. |
Smith et al., 1987, “Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen”, Science 238:1704-1707. |
Teich et al., 1984, RNA Tumor Viruses Weiss et al. (eds.), CSH-Press, pp. 949-956. |
H. Varmus, 1988, “Retroviruses”, Science 240:1427-1439. |
Weiss et al., 1996, “HIV receptors and the pathogenesis of AIDS”, Science 272:1885-1886. |
Willey et al., 1988, “In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity”, J. Virol. 62:139-147. |
Yarchoan et al., 1989, “Phase 1 study of the administration of recombinant soluble CD4 (rCD4) by continuous infusion to patients with AIDS or ARC”, Proc. 5th Int. Conf. on AIDS MCP 137, p. 564. |
Yoshida et al., 1995, “Molecular cloning of a novel C or y type chemokine, SCM-1”, FEBS Lett. 360:155-159. |
Zhang et al., 1996, “HIV-1 subtype and second-receptor use”, Nature 383:768. |
Fahey et al., Clin. Exp. Immunol. 88:1-5, 1992.* |
Fox, J.L., Bio/Technology 12:128, Feb. 1994.* |
Haynes et al., Ann. Med. 28:39-41, 1996. |